Abstract. Amyloid beta peptide (A␤) is widely believed to play a central and etiological role in Alzheimer disease (AD). A␤ has been shown to have cytotoxic effects in neural cells, although the mechanism by which it does this is still unclear. To examine the involvement of the apoptotic cascade in A␤-induced cell death, we used mice deficient in caspase-3 (CPP 32), a key protease in this cascade. We microinjected A␤ 1-40 into hippocampal regions of the brains of adult mice because AD is an adult-onset disease. We found significant cellular loss in the hippocampal regions of wild-type mice and dramatic rescue of neuronal cell death in caspase-3-deficient mice, with a gene dosage effect. In addition to adult mice, we observed little A␤-induced death of cultured neurons prepared from fetal brains of caspase-3-deficient mice but did observe death of such neurons from wild-type mice. The difference in A␤-induced neuronal death between wild-type and caspase-3-deficient mice was highly significant, indicating that A␤-induced neuronal death is mediated in vivo as well as in vitro by the caspase-3 apoptotic cascade.
INTRODUCTION
Alzheimer disease (AD) is a progressive neurodegenerative disease of the central nervous system characterized by neuropathological deposition of amyloid ␤ peptides (A␤). A␤ is the major component of extracellular senile plaques, which are comprised of 42/43 or 40 amino acids (referred to as A␤ and A␤ , respectively) (1, 2) . These peptides are produced in the metabolic processing of amyloid precursor protein (APP) (3, 4) . Familial AD caused by genetic mutations is associated with either increased A␤ (5, 6) or increased total A␤ (7) . A␤ is thought to play an important role in neurotoxicity both in vitro and in vivo (8) (9) (10) (11) . A␤-toxicity has been reported to induce oxidative stress-mediated neuronal death (12) and apoptotic neuronal death in vitro (13) (14) (15) and in vivo (16) .
However, there is disagreement regarding the relationship between apoptosis and A␤-induced cell death. For instance, apoptosis-related proteins are reported to change in AD brain or to be associated with neuropathological changes (17) (18) (19) (20) (21) (22) (23) , while little difference was observed in caspase-3 (CPP32/Yama/Apopain) mRNA or protein levels between AD and control brains (17, 19) . It is of interest to examine whether cell death mediated by caspase-3 plays a role in AD, since there have been claims that caspase-3 plays a role in cell death in experimental models of several acute and chronic neurodegenerative disorders (24) (25) (26) . Here, we focused on the in vivo and in vitro involvement of caspase-3 in A␤-induced neuronal death using caspase-3-deficient mice.
MATERIALS AND METHODS

Materials
A␤ was purchased from Anaspec, Inc. (␤-Amyloid HCl, San Jose, CA). Reverse peptide, A␤ , which was purchased from Bachem AG (Bubendorf, Switzerland), was dissolved in 2 mM HCl (1 mg/ml) to prepare HCl salt and lyophilized under freeze-drying conditions. These peptides were dissolved in filtered double-deionized water at a concentration of 1 mg/ml as stock solution. Peptide solutions were stored at Ϫ20ЊC until they were used. Before treatment in the in vivo study, peptides were preincubated at 37ЊC in 100 g/ml of filtered phosphate-buffered saline (PBS, GibcoBRL, Grand Island, NY) for 24 hours for aging. In the in vitro study, stock solution was diluted to 0.004, 0.04, 0.4, 4, and 40 M in media and applied as final concentrations of 0.002, 0.02, 0.2, 2, and 20 M by replacing half the volume of the cell culture media.
Animals
Caspase-3-deficient (caspase-3 (Ϫ/Ϫ)) mice were generated by homologous recombination in embryonic stem cells (27) . Endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts. Caspase-3 (Ϫ/Ϫ) mice were backcrossed to C57BL/6 mice (SLC, Shizuoka, Japan) for at least 7 generations and resulting offspring were subsequently bred to generate homozygous/heterozygous offspring. Wild-type C57BL/6 adult and pregnant mice were supplied by SLC. All animal experiments were performed in accordance with the Guide for Animal Experimentation, Osaka City University. Every effort was made to minimize the number of animals used and their suffering. In Vivo Injection of A␤ and Histopathological
Analysis of Tissue
Adult male caspase-3 (Ϫ/Ϫ) (10-12 months old), caspase-3 heterozygous (caspase-3 (ϩ/Ϫ)) (10-12 months old) and wildtype (caspase-3 (ϩ/ϩ)) C57BL/6 (10-12 months old, supplied by SLC and maintained for 7-9 months until these ages were reached) mice were used in the experiments. After sodium pentobarbital-induced anesthesia, the mouse was mounted on a Kopf stereotaxic head-holder (David Kopf Instruments, Tujunga, CA). Using an aseptic technique, we exposed the skull and drilled a burr hole. Based on the stereotaxic coordinates measured from bregma, 0.5 l of 100 g/ml A␤ or A␤ 40-1 was injected at a rate of 0.5 l/min into the hippocampus (AP, Ϫ2.0; ML, Ϫ1.3; V, Ϫ2.2) (28) with a 26-gauge Hamilton syringe (Hamilton Co., Reno, Nevada). An equal volume of PBS was injected at the same rate on the contralateral side to provide a matched control. The needle was kept in this configuration for 2 min to prevent reflux of the injected material along the injection track. Three, 7, 10, 14 and 28 days after injection, the mice were etherized and perfused with saline and 4% paraformaldehyde/PBS. Brains were excised and postfixed in 4% paraformaldehyde overnight.
Brain tissues were paraffin-embedded, sectioned coronally at 10 m, mounted, and subjected to cresyl violet staining. A series of every 2 in 3 sections was stained with cresyl violet. Sections in which the needle track could be identified were used for further analysis. Determinations of neurons were performed at ϫ75 magnification and the numbers of neurons in 0.13 mm 2 areas were counted on photographs at the lesion site identified from serial sections. The region counted spanned hippocampal layers CA1-2. We measured survival rates of neurons as the percentage of control side counts.
TdT-Mediated dUTP Nick End Labeling (TUNEL) Assay
Tissue sections from in vivo injection experiments were dewaxed in xylene, dehydrated through ethanol, rehydrated in PBS, and incubated with proteinase K (20 g/ml in 10 mM Tris/HCl, pH 8.0) for 20 min at 37ЊC. DNA fragmentation in the tissue sections was detected by the TUNEL method (In Situ Cell Detection Kit; Roche, Mannheim, Germany). Fluorescein dUTP at strand breaks was detected by confocal laser microscopy (LSM510; Carl Zeiss, Oberkochen, Germany). DNA fragmentation in primary-cultured neurons on 4-well chamber slide glasses (Lab-Tek II; Nalge Nunc, Naperville, IL) was fixed in PBS containing 4% paraformaldehyde and detected.
In Vitro Neurotoxicity Assay
Primary mouse cortical neuronal cultures were prepared from embryonic day 16 brains of caspase-3-deficient and wild-type mice. Cortices were isolated in chilled 1:1 solution of PBS and high-glucose Dulbecco's modified Eagle's medium (DMEM, GibcoBRL) supplemented with 50 g/ml ampicillin (half DMEM solution). Cortices were freed from the meninges and dissociated by digestion in 0.25% trypsin (Sigma) and 0.03% DNase (Worthington Biochemical Corp., Lakewood, NJ) at 37ЊC for 10 min. Trypsinization was stopped by addition of 10% fetal bovine serum (FBS)/half DMEM solution. The tissue was mildly triturated with a fire-polished Pasteur pipette. Dissociated cells were washed twice with half DMEM solution and once with DMEM with 10% FBS. Neurons were plated at 6.24 ϫ 10 4 cells per mm 2 in wells of poly l-lysine (Sigma)-coated 24-well plates. Cultures were incubated with 5% CO 2 /air at 37ЊC. After 2-day incubation (2 days in vitro, 2 DIV), culture medium was replaced by DMEM/Ham's F-12 (GibcoBRL) with 100 g/ml transferrin, 20 nM selenium, 20 nM hydrocortisone, 20 nM progesterone, and 5 g/ml bovine insulin. On 4 DIV, a half volume of the medium was exchanged with A␤ 1-40 -containing fresh medium at a final peptide concentration of 0.002, 0.02, 0.2, 2, or 20 M.
Primary-cultured neurons were fixed on 7 DIV in PBS containing 4% paraformaldehyde. After blocking with 20% fetal calf serum, fixed neurons were incubated with microtubule-associated protein 2 (MAP2) monoclonal antibody (Sigma) for 12 hours at 4ЊC. Cells were then incubated with biotinylated antimouse IgG (1:250) and developed using the ABC Elite kit (Vector Laboratories) and diaminobenzidine (Dojindo, Kumamoto, Japan). MAP2-immunoreactive cells were counted in 3 random fields per well in quadruplicate wells per embryo per condition on ϫ20 magnified photographs in each experiment.
RESULTS
In Vivo Neurodegenerative Effects of A␤ 1-40 on Cortical Neurons in Adult Brains
Aged A␤ or A␤ 40-1 was microinjected unilaterally into the adult mouse hippocampus under stereotaxic guidance. Contralateral hippocampus was infused with PBS. Injection of A␤ 1-40 caused significant neuronal loss in hippocampus at 14 days postinjection, in contrast to control experiments with PBS in wild-type mice (caspase-3 (ϩ/ ϩ) mice) (Fig. 1A) . We counted surviving neurons in cresyl violet-stained cortical sections for A␤ 1-40 -treated or control brains. Quantification of the number of neurons revealed that injection of toxic A␤ peptide into caspase-3 (ϩ/ϩ) mice induced significant neuronal loss at 14 days postinjection, with 71.5 Ϯ 5.8% neuronal survival (mean Ϯ SEM; n ϭ 4, p ϭ 0.003, Student t-test).
In contrast, injection of A␤ 1-40 peptide into caspase-3-deficient mice (caspase-3 (Ϫ/Ϫ) mice) caused virtually no neuronal loss at 14 days postinjection (101.6% Ϯ 2.5% neuronal survival (n ϭ 4), Fig. 1A, B) . Neuronal survival was significantly higher in caspase-3 (Ϫ/Ϫ) mice than in caspase-3 (ϩ/ϩ) mice (Fig. 1B , p ϭ 0.004*, AN-OVA). Injection of A␤ peptide into heterozygotes (caspase-3 (ϩ/Ϫ)) mice resulted in 87.3% Ϯ 4.3% neuronal survival (n ϭ 3) at 14 days postinjection, and this rate was also significantly higher than that in caspase-3 (ϩ/ϩ) mice (Fig. 1B , p ϭ 0.03**, ANOVA). These results indicated that caspase-3 gene dosage affected A␤ peptide-induced neuronal death in vivo. A␤-injected hippocampus shows typical degenerating neurons as shrunken morphology (Fig. 1C, middle ) in contrast to normal or intact neurons (Fig. 1C, left) . Figure 1C To confirm that the neuronal toxicity observed with in vivo injection was A␤ 1-40 -specific, injection of A␤ 40-1 with the reverse amino acid-sequence of A␤ 1-40 into caspase-3 (ϩ/ϩ) mice was performed. This resulted in 100.5% Ϯ 4.3% neuronal survival, with virtually no neuronal cell loss (n ϭ 4; Fig. 1B) .
We initially failed to find cellular loss or death in the site of injection and surrounding region early after injection. In the time-course experiment, we found that A␤-induced neurotoxicity requires a relatively long incubation period, unlike in vitro experiments, in which toxicity was observed at 3 days after addition of A␤. In our injection system, there was no neuronal loss in the hippocampus at 7 days postinjection (104.3% Ϯ 5.2% neuronal survival, n ϭ 4) in caspase-3 (ϩ/ϩ) mice. But neuronal loss was clearly detected on the tenth postinjection day and slowly increased until the fourteenth postinjection day. Such neuronal loss remains at the same level at 28 days postinjection (72.1% Ϯ 2.3%, n ϭ 2; Fig. 2 
, broken line and open circles).
To exclude the possibility that caspase-3 (Ϫ/Ϫ) mice show only delay of neuronal cell death for A␤ toxicity, we also observed the neuronal survival rate at a later time point in caspase-3 (Ϫ/Ϫ) mice in a time-course experiment. This resulted in 105.4% Ϯ 2.3% (n ϭ 3) and 103.6% Ϯ 2.7% (n ϭ 3) neuronal survival at 7 days and 28 days postinjection, respectively, with virtually no neuronal cell loss (Fig. 2, solid line and closed circles) .
We next added a TUNEL assay study to see whether DNA fragmentation occurred in the hippocampal regions. As shown in Figure 3 (upper), TUNEL-labeled tissue sections from caspase-3 (ϩ/ϩ) mice brain exhibited few TU-NEL-labeled nuclei at 3 days post-A␤-injection, while the tissue sections exhibited a marked increase in numbers of labeled nuclei (green) at 10 days postinjection (Fig. 3,  lower right) . As compared to the control side (Fig. 3 
In Vitro Neurodegenerative Effects of A␤ 1-40 on PrimaryCultured Neurons
To assess the role of caspase-3 in A␤-induced cell death in vitro, we exposed caspase-3 (ϩ/ϩ) and caspase-3 (Ϫ/Ϫ) neurons to A␤ . In caspase-3 (ϩ/ϩ) neurons, A␤ 1-40 at less than 0.2 M did not significantly decrease the number of MAP2-immunopositive neurons ( Fig. 4; broken line and open circles), but A␤ 1-40 at more than 2 M exhibited clear neuronal toxicity in a dose-dependent manner. Survival rates were 74.0% Ϯ 9.2% (mean Ϯ SEM; n ϭ 8, p ϭ 0.002, ANOVA) and 27.0% Ϯ 3.3% (p Ͻ 0.001) at A␤ 1-40 concentrations of 2 M and 20 M, respectively. In contrast, A␤ was much less toxic in caspase-3 (Ϫ/Ϫ) neurons, except at a high concentration of 20 M, at which small but significant neuronal loss occurred (72.9% Ϯ 4.6% survival rate, p ϭ 0.018, n ϭ 8) (Fig. 4; solid line and closed circles) . Notably, however, the neuronal toxicity of A␤ 1-40 at 20 M was significantly less in caspase-3 (Ϫ/Ϫ) neurons than in caspase-3 (ϩ/ϩ) neurons (p Ͻ 0.001).
To quantify the effects of A␤ 1-40 peptide on the DNA fragmentation in vitro, TUNEL assay was applied to primary culture preparations. When control medium without A␤ 1-40 was added to cell culture, TUNEL-labeled nuclei accounted for 32.3% Ϯ 4.8% (mean Ϯ SEM; n ϭ 3) and 16.8% Ϯ 3.1% of all neurons in caspase-3 (ϩ/ϩ) and (Ϫ/ Ϫ) mice, respectively. These percentages increased with A␤-treatment in both caspase-3 (ϩ/ϩ) and (Ϫ/Ϫ) mice (Fig. 4B-E) . However, it was clear that TUNEL-positive neurons were much higher in number in caspase-3 (ϩ/ϩ) neurons (49.8% Ϯ 5.2%) than in caspase-3 (Ϫ/Ϫ) neurons (19.5% Ϯ 5.3%). The increments in number induced by A␤ treatment were significantly lower in caspase-3 (Ϫ/Ϫ) neurons than in caspase-3 (ϩ/ϩ) neurons (2.7% Ϯ 2.2% and 17.5% Ϯ 1.3%, respectively; mean Ϯ SEM, n ϭ 3, p ϭ 0.05*, Mann-Whitney test) (Fig. 4F) .
DISCUSSION
Wild-type adult mice, but not caspase-3-deficient mice, were affected by direct intracerebral injection of A␤ in vivo. We also observed in vitro that A␤ 1-40 induced significant and reproducible death of neurons from fetal brains of caspase-3 (ϩ/ϩ) mice, but failed to cause any neuronal cell death in fetal brains from caspase-3 (Ϫ/Ϫ) mice except at a high concentration. These findings are consistent with our in vivo results and previous in vitro reports (29) (30) (31) (32) , but contrary to the in vitro report that A␤-induced cell death was relatively independent of caspase-3 (15) . This difference in dependence on caspase-3 may, at least in part, be explained by the finding that A␤ toxicity depended on stage of development or culture (8, 33) .
Several lines of evidence suggest the involvement of APP (34) (35) (36) or fragments derived from it (37) (38) (39) in the A␤-induced caspase cascade. These observations indicate the presence of a pathway from A␤, as an in vivo trigger signal, to neuronal cell death through APP and caspase-3. It is also likely that other pathways mediated by APPderived fragments (37) or A␤-binding proteins/receptors, such as scavenger receptor (40, 41) , acetylcholine receptor (42), or insulin receptor (43) , play roles in A␤-induced toxicity themselves and/or together with APP. Whether A␤ activates caspase-3 directly or via APP and/ or other proteins, our findings suggest that caspase-3 is a key molecule in A␤-induced neuronal loss. Although our in vivo model suggests that a relation between apoptosis and A␤ may exist, whether apoptosis occurs in AD brain remains unclear (44) .
As described here, A␤-induced neuronal cell death is delayed in vivo compared with in vitro. Activated astrocytes and microglia are known to associate with aggregated A␤ deposits in AD brain (45) , and they seem to be the major source of pro-inflammatory cytokines, such as interleukin-1␤ (46), tumor necrosis factor-␣ and others (47) . This increase in secretion of inflammatory mediators is potentially toxic to nearby neurons (47) . Activated microglia produce nitric oxide and superoxide following expression of inducible nitric-oxide synthase (iNOS), and these molecules are neurotoxic (48, 49) . Astrocytes comprise a large cell population in the central nervous system. They interact with neurons to provide structural, metabolic, and trophic support, and help to maintain metabolic homeostasis as well as the blood-brain barrier (49, 50) . A␤-induced oxidative stress in astrocytes may contribute to disrupting the function of glutamate transporters in AD (51) , which may result in over-stimulation of glutamate receptors, leading to neuronal death (52) . These complex toxic cascades involving glial cells, cytokines, and neurotransmitters may contribute to A␤-induced toxicity in vivo and may be related to the delay of A␤-induced neuronal cell death in vivo.
A␤ itself does not always show the same toxicity, and some other factors, such as excitotoxins, oxidative stress, or glucose metabolism, may act synergistically with A␤ to cause neuronal cell death (53) . As a result, an effective A␤ concentration may vary slightly from patient to patient, and evidence exists that A␤ sensitivity also varies with species and age (33) . For instance, greater sensitivity to in vivo A␤ neurotoxic effects was observed in primates than in rats, and in older primates than in younger primates. These findings are particularly important taking into account that AD is an adult-onset disease. It is a well-established fact that the cerebral A␤ concentration in patients with AD is lower than an effective A␤ concentration in vitro (5, (54) (55) (56) . Taken together, the neuronal cell loss in the present in vivo experiment using aged mice might occur at a lower concentration of A␤. Moreover, this effective concentration in vivo is of interest in view of the toxic form of A␤, as recent evidence strongly suggests that soluble A␤ oligomers are neurotoxic at low concentrations (57) (58) (59) (60) (61) . A toxic form of in vivo A␤ remains to be studied.
The biochemical hallmark of apoptosis is degradation of DNA, and TUNEL-assay can detect DNA fragmentation. In our in vitro experiments, many TUNEL-positive cells were detected, however, not all of them died, because DNA fragmentation can occur during repair of reversibly damaged DNA, in necrosis, autolysis, and oxidative damage (44, 62, 63) .
Our results suggest that A␤ could function as an extracellular signal molecule for caspase-3 activation in AD. The yet unknown relationship between a soluble A␤ oligomer and amyloid burden as a sequestering reservoir remains to be studied. However, it is likely that A␤ derived from APP functions as a key suicide molecule through caspase-3 in AD, and that genetic factors such as mutations of APP, presenilin-1, or presenilin-2 enhance this suicide cycle.
